Recalls & Warnings October 08, 2015 FDA Warns Seller of Omega-3 "Concussion" Supplement for Drug Claims On October 1, 2015, the FDA issued a warning letter to MPH Nutrition, LLC, following a review of the company's website which found statements made about Re:Mind Recover, a supplement promoted for recovery from concussions, to be drug claims which are not permitted for supplements
The thumbnail below links to a short educational video that walks through typical handling practices, such as storing the vial at appropriate temperatures, reconstituting with bacteriostatic water under a hood, and labeling aliquots with concentration and lot number
The titration schedule itself (0.25 0.5 1.0 1.7 2.4 mg at ~4-week steps) is not a research artifact
In most cases, you should not use decongestants for more than 1 week, but this time may differ between products
Lot:VL-BPC-2026-0412 BPC-157 is a synthetic peptide sequence referenced extensively in in vitro and preclinical research literature
C-reactive protein as an early predictor of COVID-19 severity
